Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: NIACIN, . Treffer: 10
2022
Berger, MM; Shenkin, A; Schweinlin, A; Amrein, K; Augsburger, M; Biesalski, HK; Bischoff, SC; Casaer, MP; Gundogan, K; Lepp, HL; de, Man, AME; Muscogiuri, G; Pietka, M; Pironi, L; Rezzi, S; Cuerda, C
ESPEN micronutrient guideline.
Clin Nutr. 2022; 41(6): 1357-1424.
Doi: 10.1016/j.clnu.2022.02.015
Web of Science
PubMed
FullText
FullText_MUG
2021
Abdellatif, M; Baur, JA
NAD(+) metabolism and cardiometabolic health: the human evidence
CARDIOVASC RES. 2021; 117(9): E106-E109.
Doi: 10.1093/cvr/cvab212
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Falb, T; Malle, EM; Haas, A; Weger, M; Wedrich, A
STELLATE NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS IN A PATIENT WITH MACULAR TELANGIECTASIA TYPE 2.
Retin Cases Brief Rep. 2021; 15(3):335-338
Doi: 10.1097/ICB.0000000000000801
PubMed
FullText
FullText_MUG
2019
Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Sedej, M; Roula, D; Pursche, B; Wolf, A; Zoidl, M; Steinbauer, E; Gruber, V; Greinix, HT; Prochazka, KT; Thallinger, GG; Heinemann, A; Beham-Schmid, C; Neumeister, P; Wrodnigg, TM; Fechter, K; Deutsch, AJ
The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Int J Mol Sci. 2019; 20(19):
Doi: 10.3390/ijms20194740
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Minto, C; Vecchio, MG; Lamprecht, M; Gregori, D
Definition of a tolerable upper intake level of niacin: a systematic review and meta-analysis of the dose-dependent effects of nicotinamide and nicotinic acid supplementation.
Nutr Rev. 2017; 75(6):471-490
Doi: 10.1093/nutrit/nux011
Web of Science
PubMed
FullText
FullText_MUG
2012
Mahdy Ali, K; Wonnerth, A; Huber, K; Wojta, J
Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.
Br J Pharmacol. 2012; 167(6):1177-1194
Doi: 10.1111/j.1476-5381.2012.02081.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Philipose, S; Konya, V; Lazarevic, M; Pasterk, LM; Marsche, G; Frank, S; Peskar, BA; Heinemann, A; Schuligoi, R
Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation.
PLoS One. 2012; 7(8):e40222-e40222
Doi: 10.1371/journal.pone.0040222
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Konrad, M; Nieman, DC; Henson, DA; Kennerly, KM; Jin, F; Wallner-Liebmann, SJ
The acute effect of ingesting a quercetin-based supplement on exercise-induced inflammation and immune changes in runners.
Int J Sport Nutr Exerc Metab. 2011; 21(4):338-346
Doi: 10.1123/ijsnem.21.4.338
Web of Science
PubMed
FullText
FullText_MUG
2003
Ballantyne, CM; Corsini, A; Davidson, MH; Holdaas, H; Jacobson, TA; Leitersdorf, E; März, W; Reckless, JP; Stein, EA
Risk for myopathy with statin therapy in high-risk patients.
Arch Intern Med. 2003; 163(5):553-564
Doi: 10.1001/archinte.163.5.553
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1985
Gurakar, A; Hoeg, JM; Kostner, G; Papadopoulos, NM; Brewer, HB
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.
Atherosclerosis. 1985; 57(2-3):293-301
Doi: 10.1016/0021-9150(85)90041-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar